Quarterly report [Sections 13 or 15(d)]

Consolidated Statements of Cash Flows

v3.25.4
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
3 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Cash flows from operating activities (continuing)    
Net loss $ (614) $ (1,906)
Loss from discontinued operations, net of tax 337 1,551
Adjustments to reconcile net loss to net cash provided by operating activities:    
Depreciation and amortization 1,615 1,513
Amortization of premium and discount on investments, net (117) (766)
Deferred taxes (375) (135)
Stock-based compensation 1,271 1,050
Changes in operating assets and liabilities, net of acquired amounts:    
Accounts receivable 3,020 3,577
Inventories, net 1,830 6,279
Other assets (2,905) (903)
Accounts payable and accrued expenses (5,502) (2,221)
Net cash provided by operating activities (continuing) (1,440) 8,039
Cash flows from investing activities (continuing)    
Purchases of property, plant and equipment and intangible assets (988) (1,751)
Purchases of investments (19,953) (39,015)
Proceeds from maturities of investments 21,660 54,476
Cash paid on disposal of business (1,012) 0
Net cash used in investing activities (continuing) (293) 13,710
Cash flows from financing activities (continuing)    
Proceeds from issuance of common stock under employee stock purchase plan 239 301
Repurchase of shares for payment of withholding taxes for vested restricted stock grants (997) (491)
Withholding related to exercise of stock options (57) 0
Repurchase of common stock (5,279) (6,275)
Net cash (used in) provided by financing activities (continuing) (6,094) (6,465)
Cash flows from discontinued operations    
Net cash provided by (used in) operating activities 1,380 (889)
Net cash used in investing activities 0 (318)
Net cash provided by (used in) financing activities (1,196) 77
Net cash provided by (used in) discontinued operations 184 (1,130)
Effect of exchange rates on cash and cash equivalents    
Effect of exchange rates on cash and cash equivalents (13) 132
Net increase (decrease) in cash and cash equivalents (7,656) 14,286
Change in cash held for sale    
Change in cash held for sale 42 1,065
Cash and cash equivalents, beginning of period 21,493 14,148
Cash and cash equivalents, end of period 13,879 29,499
Supplemental disclosures for cash flow information    
Cash paid for income taxes (12) 405
Non-cash financing activities    
Cashless exercise of stock options $ 419 $ 9